BREXPIPRAZOLE
APOTEX · BREXPIPRAZOLE
Open FDA's page for this record- Application number
- ANDA213731
- Sponsor name
- APOTEX
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250224
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Application docs
- ID
- 77367
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/213731Orig1s000TA_ltr.pdf
- Date
- 20240131
- Type
- Letter
- Products
- Product number
- 005
- Reference drug
- No
- Brand name
- BREXPIPRAZOLE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- BREXPIPRAZOLE
- Strength
- 3MG
- Product number
- 003
- Reference drug
- No
- Brand name
- BREXPIPRAZOLE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- BREXPIPRAZOLE
- Strength
- 1MG
- Product number
- 001
- Reference drug
- No
- Brand name
- BREXPIPRAZOLE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- BREXPIPRAZOLE
- Strength
- 0.25MG
- Product number
- 004
- Reference drug
- No
- Brand name
- BREXPIPRAZOLE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- BREXPIPRAZOLE
- Strength
- 2MG
- Product number
- 002
- Reference drug
- No
- Brand name
- BREXPIPRAZOLE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- BREXPIPRAZOLE
- Strength
- 0.5MG
